In a world where healthcare disparities often leave vulnerable populations without essential resources, we are proud to announce an impactful collaboration that promises to bridge those gaps for those living with Type 1 Diabetes (T1D) in low- and middle-income countries (LMICs) like Cambodia, Laos, and Myanmar. This initiative powered by Sanofi's Global Health Unit for Sustainable Impact is the result of a partnership between Action4Diabetes (A4D) and Sanofi Global Health Unit (GHU). Together, we can work toward making a substantial difference in the lives of individuals with T1D in these underserved regions.
Without access to the right education and essential medical supplies, individuals living with T1D may face a lifetime of difficulty and struggling. Sanofi GHU's commitment to funding T1D education and healthcare capacity building is poised to make a significant impact. By channelling resources into these critical areas, we aim to provide those living in Cambodia, Laos, and Myanmar with the T1D education and healthcare services they urgently require.
When it comes to building T1D education and awareness, there is a two-pronged approach that this partnership is committed to. The first is the focus on diabetes education, primarily through A4D’s T1D Family Camps. These camps serve as invaluable educational platforms where young people living with T1D can learn how to manage their condition, develop essential life skills and self-confidence, and build crucial bonds and relationships. This psychosocial development is an integral part of coping with T1D and living a fulfilling life. By providing a supportive and nurturing environment, these camps empower T1D individuals to thrive.
The next is working on health capacity building in the three supported countries. Starting with a training for nurses in Cambodia this August, A4D will continue to work with Sanofi GHU to train and equip local healthcare professionals, empowering them with the knowledge and skills necessary to diagnose and manage T1D effectively. This commitment in capacity building is an investment in the future of healthcare for those living with T1D.
Sanofi GHU will also provide funding to A4D to ensure a steady supply of blood glucose monitoring supplies to all the young people on A4D’s programme. These supplies play a vital role in the effective management of their T1D, not only enhancing their quality of life but also helping to prevent serious complications like diabetic ketoacidosis (DKA). In addition to this, systematic management and monitoring of T1D health outcomes is an important part of the collaboration. The understanding of the data collected will help A4D identify those who are higher risk, or may require additional support.
This powerful partnership will make a profound difference for individuals with T1D in Cambodia, Laos, and Myanmar by closing the healthcare gaps that have plagued these countries for too long. A4D is proud to have such a partner in Sanofi GHU, and look forward to achieving many milestones together.
